[{"id":"29615e37-bb63-4054-a44c-541e878490a0","acronym":"","url":"https://clinicaltrials.gov/study/NCT05358379","created_at":"2024-02-07T19:21:22.852Z","updated_at":"2024-07-02T16:35:20.542Z","phase":"Phase 1/2","brief_title":"A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma","source_id_and_acronym":"NCT05358379","lead_sponsor":"Cyclacel Pharmaceuticals, Inc.","biomarkers":" PLK1 • CDKN1A","pipe":" | ","alterations":" MYC expression","tags":["PLK1 • CDKN1A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MYC expression"],"overall_status":"Recruiting","enrollment":" Enrollment 330","initiation":"Initiation: 04/14/2022","start_date":" 04/14/2022","primary_txt":" Primary completion: 08/01/2025","primary_completion_date":" 08/01/2025","study_txt":" Completion: 11/01/2025","study_completion_date":" 11/01/2025","last_update_posted":"2024-02-07"},{"id":"bac1b09e-9082-44c7-ba9d-455e8eda253a","acronym":"","url":"https://clinicaltrials.gov/study/NCT01510405","created_at":"2021-01-18T06:20:51.413Z","updated_at":"2024-07-02T16:35:41.477Z","phase":"","brief_title":"Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung Cancer","source_id_and_acronym":"NCT01510405","lead_sponsor":"Dartmouth-Hitchcock Medical Center","biomarkers":" AURKA • PLK1","pipe":"","alterations":" ","tags":["AURKA • PLK1"],"overall_status":"Completed","enrollment":" Enrollment 42","initiation":"Initiation: 07/01/2010","start_date":" 07/01/2010","primary_txt":" Primary completion: 04/01/2020","primary_completion_date":" 04/01/2020","study_txt":" Completion: 04/01/2020","study_completion_date":" 04/01/2020","last_update_posted":"2023-08-01"}]